Literature DB >> 22771948

The endoglycosidase heparanase enters the nucleus of T lymphocytes and modulates H3 methylation at actively transcribed genes via the interplay with key chromatin modifying enzymes.

Yi Qing He1, Elissa L Sutcliffe, Karen L Bunting, Jasmine Li, Katharine J Goodall, Ivan K A Poon, Mark D Hulett, Craig Freeman, Anjum Zafar, Russell L McInnes, Toshiki Taya, Christopher R Parish, Sudha Rao.   

Abstract

The methylation of histones is a fundamental epigenetic process regulating gene expression programs in mammalian cells. Dysregulated patterns of histone methylation are directly implicated in malignant transformation. Here, we report the unexpected finding that the invasive extracellular matrix degrading endoglycosidase heparanase enters the nucleus of activated human T lymphocytes and regulates the transcription of a cohort of inducible immune response genes by controlling histone H3 methylation patterns. It was found that nuclear heparanase preferentially associates with euchromatin. Genome-wide ChIP-on-chip analyses showed that heparanase is recruited to both the promoter and transcribed regions of a distinct cohort of transcriptionally active genes. Knockdown and overexpression of the heparanase gene also showed that chromatin-bound heparanase is a prerequisite for the transcription of a subset of inducible immune response genes in activated T cells. Furthermore, the actions of heparanase seem to influence gene transcription by associating with the demethylase LSD1, preventing recruitment of the methylase MLL and thereby modifying histone H3 methylation patterns. These data indicate that heparanase belongs to an emerging class of proteins that play an important role in regulating transcription in addition to their well-recognized extra-nuclear functions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22771948      PMCID: PMC3616083          DOI: 10.4161/trns.19998

Source DB:  PubMed          Journal:  Transcription        ISSN: 2154-1272


  79 in total

Review 1.  Histone modification therapy of cancer.

Authors:  Chiara Biancotto; Gianmaria Frigè; Saverio Minucci
Journal:  Adv Genet       Date:  2010       Impact factor: 1.944

2.  Epigenetic profiling at mouse imprinted gene clusters reveals novel epigenetic and genetic features at differentially methylated regions.

Authors:  Scott V Dindot; Richard Person; Mark Strivens; Rejinaldo Garcia; Arthur L Beaudet
Journal:  Genome Res       Date:  2009-06-19       Impact factor: 9.043

Review 3.  Coordinated chromatin control: structural and functional linkage of DNA and histone methylation.

Authors:  Xiaodong Cheng; Robert M Blumenthal
Journal:  Biochemistry       Date:  2010-04-13       Impact factor: 3.162

4.  Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4.

Authors:  Eric Metzger; Axel Imhof; Dharmeshkumar Patel; Philip Kahl; Katrin Hoffmeyer; Nicolaus Friedrichs; Judith M Müller; Holger Greschik; Jutta Kirfel; Sujuan Ji; Natalia Kunowska; Christian Beisenherz-Huss; Thomas Günther; Reinhard Buettner; Roland Schüle
Journal:  Nature       Date:  2010-03-14       Impact factor: 49.962

5.  A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics.

Authors:  Uri Barash; Victoria Cohen-Kaplan; Gil Arvatz; Svetlana Gingis-Velitski; Flonia Levy-Adam; Ofer Nativ; Ronen Shemesh; Michal Ayalon-Sofer; Neta Ilan; Israel Vlodavsky
Journal:  FASEB J       Date:  2009-12-09       Impact factor: 5.191

Review 6.  New roles of flavoproteins in molecular cell biology: histone demethylase LSD1 and chromatin.

Authors:  Federico Forneris; Elena Battaglioli; Andrea Mattevi; Claudia Binda
Journal:  FEBS J       Date:  2009-07-14       Impact factor: 5.542

7.  LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer.

Authors:  Yan Wang; Hua Zhang; Yupeng Chen; Yimin Sun; Fen Yang; Wenhua Yu; Jing Liang; Luyang Sun; Xiaohan Yang; Lei Shi; Ruifang Li; Yanyan Li; Yu Zhang; Qian Li; Xia Yi; Yongfeng Shang
Journal:  Cell       Date:  2009-08-21       Impact factor: 41.582

Review 8.  Epigenetics in cancer: targeting chromatin modifications.

Authors:  Leigh Ellis; Peter W Atadja; Ricky W Johnstone
Journal:  Mol Cancer Ther       Date:  2009-06-09       Impact factor: 6.261

9.  Interplay between chromatin remodeling and epigenetic changes during lineage-specific commitment to granzyme B expression.

Authors:  Torsten Juelich; Elissa L Sutcliffe; Elissa Sutcliffe; Alice Denton; Yiqing He; Peter C Doherty; Christopher R Parish; Christopher Parish; Stephen J Turner; Steven J Turner; David J Tremethick; David Tremethick; Sudha Rao
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

10.  Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency.

Authors:  Yu Liang; Jodi L Vogel; Aarthi Narayanan; Hua Peng; Thomas M Kristie
Journal:  Nat Med       Date:  2009-10-25       Impact factor: 53.440

View more
  33 in total

1.  Viral Activation of Heparanase Drives Pathogenesis of Herpes Simplex Virus-1.

Authors:  Alex M Agelidis; Satvik R Hadigal; Dinesh Jaishankar; Deepak Shukla
Journal:  Cell Rep       Date:  2017-07-11       Impact factor: 9.423

2.  High glucose facilitated endothelial heparanase transfer to the cardiomyocyte modifies its cell death signature.

Authors:  Fulong Wang; Jocelyn Jia; Nathaniel Lal; Dahai Zhang; Amy Pei-Ling Chiu; Andrea Wan; Israel Vlodavsky; Bahira Hussein; Brian Rodrigues
Journal:  Cardiovasc Res       Date:  2016-12       Impact factor: 10.787

3.  Heparanase and Chemotherapy Synergize to Drive Macrophage Activation and Enhance Tumor Growth.

Authors:  Udayan Bhattacharya; Lilach Gutter-Kapon; Tal Kan; Ilanit Boyango; Uri Barash; Shi-Ming Yang; JingJing Liu; Miriam Gross-Cohen; Ralph D Sanderson; Yuval Shaked; Neta Ilan; Israel Vlodavsky
Journal:  Cancer Res       Date:  2019-11-05       Impact factor: 12.701

4.  Heparanase is required for activation and function of macrophages.

Authors:  Lilach Gutter-Kapon; Dror Alishekevitz; Yuval Shaked; Jin-Ping Li; Ami Aronheim; Neta Ilan; Israel Vlodavsky
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-14       Impact factor: 11.205

Review 5.  Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.

Authors:  Ralph D Sanderson; Michael Elkin; Alan C Rapraeger; Neta Ilan; Israel Vlodavsky
Journal:  FEBS J       Date:  2016-11-16       Impact factor: 5.542

Review 6.  Mechanisms of heparanase inhibitors in cancer therapy.

Authors:  Benjamin Heyman; Yiping Yang
Journal:  Exp Hematol       Date:  2016-08-26       Impact factor: 3.084

Review 7.  Versatile role of heparanase in inflammation.

Authors:  Rachel Goldberg; Amichay Meirovitz; Nir Hirshoren; Raanan Bulvik; Adi Binder; Ariel M Rubinstein; Michael Elkin
Journal:  Matrix Biol       Date:  2013-03-13       Impact factor: 11.583

Review 8.  Involvement of heparanase in atherosclerosis and other vessel wall pathologies.

Authors:  Israel Vlodavsky; Miry Blich; Jin-Ping Li; Ralph D Sanderson; Neta Ilan
Journal:  Matrix Biol       Date:  2013-03-13       Impact factor: 11.583

Review 9.  The heparanase/syndecan-1 axis in cancer: mechanisms and therapies.

Authors:  Vishnu C Ramani; Anurag Purushothaman; Mark D Stewart; Camilla A Thompson; Israel Vlodavsky; Jessie L-S Au; Ralph D Sanderson
Journal:  FEBS J       Date:  2013-03-04       Impact factor: 5.542

Review 10.  Opposing Functions of Heparanase-1 and Heparanase-2 in Cancer Progression.

Authors:  Israel Vlodavsky; Miriam Gross-Cohen; Marina Weissmann; Neta Ilan; Ralph D Sanderson
Journal:  Trends Biochem Sci       Date:  2017-11-20       Impact factor: 13.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.